Stone Ridge Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,107
Closed -$727K 793
2020
Q1
$727K Sell
4,107
-14,100
-77% -$2.65M 0.08% 286
2019
Q4
$3.48M Hold
18,207
0.21% 82
2019
Q3
$3.06M Buy
18,207
+200
+1% +$32.6K 0.18% 107
2019
Q2
$3.02M Sell
18,007
-8,700
-33% -$1.2M 0.18% 112
2019
Q1
$3.91M Buy
26,707
+6,908
+35% +$1M 0.22% 78
2018
Q4
$2.65M Buy
19,799
+9,292
+88% +$1.52M 0.16% 101
2018
Q3
$2M Buy
10,507
+4,764
+83% +$875K 0.11% 192
2018
Q2
$957K Buy
5,743
+4,243
+283% +$681K 0.05% 442
2018
Q1
$252K Buy
+1,500
New +$252K 0.01% 1132
2016
Q2
Sell
-1,237
Closed -$332K 55
2016
Q1
$332K Hold
1,237
2.01% 9
2015
Q4
$387K Sell
1,237
-500
-29% -$149K 1.31% 9
2015
Q3
$472K Hold
1,737
1.87% 7
2015
Q2
$527K Hold
1,737
1.22% 8
2015
Q1
$517K Buy
1,737
+237
+16% +$67.6K 1.29% 4
2014
Q4
$386K Buy
+1,500
New +$375K 0.81% 14

Other funds holding AGN

Stone Ridge Asset Management's AGN Position: Q2 2020 in Review

Stone Ridge Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,107 shares — an estimated $727K sold.

Stone Ridge Asset Management first reported a position in AGN in Q4 2014 and held it in 15 quarters. The position peaked at $3.91M in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Stone Ridge Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 4,107 Allergan plc shares in Q2 2020, an estimated $727K.
  • Stone Ridge Asset Management first reported a position in Allergan plc in Q4 2014 and held it in 15 quarters.
  • Stone Ridge Asset Management's Allergan plc position peaked at $3.91M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Stone Ridge Asset Management's 13F filing for Q2 2020, filed 23 Jul 2020.